A Feasibility Study for Testing the Effects of Extended-release Naltrexone (Vivitrol) on Recidivism and Other Participant Outcomes in Drug Court Settings
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Naltrexone (Primary) ; Naltrexone (Primary)
- Indications Opioid abuse
- Focus Therapeutic Use
- 28 Sep 2017 Status changed from not yet recruiting to recruiting.
- 15 Sep 2017 Planned End Date changed from 1 Mar 2019 to 1 Jun 2019.
- 15 Sep 2017 Planned primary completion date changed from 1 Mar 2019 to 1 Jun 2019.